CollaborationCreates "Targeted RNA Degraders" by BringingTogether Amgen's Induced Proximity Platform Discovery Expertise and Arrakis' Leading-edge RNA-targetedDrugDiscovery Platform
PR Newswire
THOUSAND OAKS, Calif. and WALTHAM, Mass., Jan. 11, 2022